How The Market For Tesaro's Niraparib Plays Out Following Early FDA Approval
March 28, 2017 at 08:46 AM EDT
TESARO Inc (NASDAQ: TSRO)'s niraparib has received FDA approval, ahead of its Prescription Drug User Fee Act date of June ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.